Yair Alster

575 total citations
23 papers, 398 citations indexed

About

Yair Alster is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Yair Alster has authored 23 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Ophthalmology, 11 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Yair Alster's work include Retinal Diseases and Treatments (10 papers), Glaucoma and retinal disorders (6 papers) and Ocular Surface and Contact Lens (6 papers). Yair Alster is often cited by papers focused on Retinal Diseases and Treatments (10 papers), Glaucoma and retinal disorders (6 papers) and Ocular Surface and Contact Lens (6 papers). Yair Alster collaborates with scholars based in Israel, United States and Australia. Yair Alster's co-authors include Anat Loewenstein, Igal Leibovitch, Yuval Yassur, Michaela Goldstein, Omer Rafaeli, Adiel Barak, Rafael Malach, Isaac Avni, Moshé Lazar and Douglas G. Day and has published in prestigious journals such as Ophthalmology, American Journal of Ophthalmology and Investigative Ophthalmology & Visual Science.

In The Last Decade

Yair Alster

23 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yair Alster Israel 10 298 224 93 51 33 23 398
Klemens Fondi Austria 16 398 1.3× 336 1.5× 140 1.5× 24 0.5× 15 0.5× 21 508
Alexander H. Rulo Netherlands 10 423 1.4× 155 0.7× 126 1.4× 40 0.8× 58 1.8× 11 500
Fatih Özçura Türkiye 13 365 1.2× 267 1.2× 284 3.1× 36 0.7× 48 1.5× 50 574
Nadia Kaiserman Israel 8 260 0.9× 126 0.6× 153 1.6× 41 0.8× 55 1.7× 13 371
M Blumenthal Israel 19 727 2.4× 415 1.9× 103 1.1× 40 0.8× 74 2.2× 60 850
D Chiseliţă Romania 12 377 1.3× 272 1.2× 101 1.1× 38 0.7× 21 0.6× 57 468
Sunil Deokule United States 11 374 1.3× 272 1.2× 53 0.6× 27 0.5× 25 0.8× 19 434
Shérif M. El-Harazi United States 12 372 1.2× 123 0.5× 97 1.0× 20 0.4× 31 0.9× 24 450
Velota Sung United Kingdom 14 507 1.7× 268 1.2× 48 0.5× 36 0.7× 17 0.5× 32 564
Tamer Takmaz Türkiye 13 370 1.2× 217 1.0× 153 1.6× 21 0.4× 91 2.8× 33 495

Countries citing papers authored by Yair Alster

Since Specialization
Citations

This map shows the geographic impact of Yair Alster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yair Alster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yair Alster more than expected).

Fields of papers citing papers by Yair Alster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yair Alster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yair Alster. The network helps show where Yair Alster may publish in the future.

Co-authorship network of co-authors of Yair Alster

This figure shows the co-authorship network connecting the top 25 collaborators of Yair Alster. A scholar is included among the top collaborators of Yair Alster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yair Alster. Yair Alster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Stapleton, Fiona, Jacqueline Tan, Lyndon Jones, et al.. (2024). AZR-MD-001 0.5% selenium sulfide ophthalmic ointment for the treatment of contact lens discomfort: A vehicle-controlled, randomized, clinical trial. The Ocular Surface. 38. 431–439. 1 indexed citations
3.
Watson, Stephanie L., Lyndon Jones, Fiona Stapleton, et al.. (2023). Efficacy and safety of AZR-MD-001 selenium sulfide ophthalmic ointment in adults with meibomian gland dysfunction: A vehicle-controlled, randomized clinical trial. The Ocular Surface. 29. 537–546. 11 indexed citations
4.
Epstein-Barash, Hila, et al.. (2021). Keratolytic and Keratostatic activity of Selenium Disulfide and its disease modifying role in Meibomian Gland Disease. Investigative Ophthalmology & Visual Science. 62(8). 692–692. 5 indexed citations
5.
Alster, Yair, et al.. (2021). Lipogenic activity of Selenium Disulfide and its role in enhancing lipid production in Meibomian Glands. Investigative Ophthalmology & Visual Science. 62(8). 693–693. 4 indexed citations
6.
Loewenstein, Anat, Guna Laganovska, Neil M. Bressler, et al.. (2020). Phase 1 Clinical Study of the Port Delivery System with ranibizumab for continuous treatment of neovascular age-related macular degeneration. 61(7). 4201–4201. 4 indexed citations
7.
Brandt, James D., Kenneth Sall, Harvey Dubiner, et al.. (2016). Six-Month Intraocular Pressure Reduction with a Topical Bimatoprost Ocular Insert. Ophthalmology. 123(8). 1685–1694. 81 indexed citations
8.
Anderson, Carolyn J., et al.. (2009). PREFERENTIAL HYPERACUITY PERIMETRY TO DETECT HYDROXYCHLOROQUINE RETINAL TOXICITY. Retina. 29(8). 1188–1192. 5 indexed citations
9.
Alster, Yair, Neil M. Bressler, Susan B. Bressler, et al.. (2005). Preferential Hyperacuity Perimeter (PreView PHP) for Detecting Choroidal Neovascularization Study. Ophthalmology. 112(10). 1758–1765. 62 indexed citations
10.
Goldstein, Michaella, Igal Leibovitch, Shlomo Levin, et al.. (2004). Red blood cell membrane mechanical fluctuations in non-proliferative and proliferate diabetic retinopathy. Graefe s Archive for Clinical and Experimental Ophthalmology. 242(11). 937–943. 8 indexed citations
11.
Leibovitch, Igal, Anat Loewenstein, Yair Alster, et al.. (2004). Interferon Alpha-2a for Proliferative Diabetic Retinopathy After Complete Laser Panretinal Photocoagulation Treatment. Ophthalmic surgery, lasers & imaging retina. 35(1). 16–22. 15 indexed citations
12.
Leibovitch, Igal, et al.. (2003). Macular Hole Secondary to Branch Retinal Vein Occlusion Diagnosed by Retinal Thickness Analyzer. Ophthalmic surgery, lasers & imaging retina. 34(1). 53–56. 13 indexed citations
13.
Loewenstein, Anat, Rafael Malach, Michaela Goldstein, et al.. (2003). Replacing the Amsler grid. Ophthalmology. 110(5). 966–970. 83 indexed citations
14.
Leibovitch, Igal, Yair Alster, J M Scherrmann, et al.. (2003). Colchicine in Tear Fluid of Treated Patients With Familial Mediterranean Fever. Cornea. 22(3). 191–193. 8 indexed citations
15.
Alster, Yair, et al.. (1999). Effectiveness of sub-Tenon’s versus peribulbar anesthesia in extracapsular cataract surgery. Journal of Cataract & Refractive Surgery. 25(12). 1646–1650. 20 indexed citations
16.
Stolovitch, Chaim, Yair Alster, Michaela Goldstein, Anat Loewenstein, & Melissa Lazar. (1998). Application of Cyclopentolate 1% to the Medial Canthus in Children. Journal of Pediatric Ophthalmology & Strabismus. 35(3). 182–184. 4 indexed citations
17.
Alster, Yair. (1998). Low-Frequency Submicron Fluctuations of Red Blood Cells in Diabetic Retinopathy. Archives of Ophthalmology. 116(10). 1321–1321. 8 indexed citations
18.
Alster, Yair, et al.. (1996). Dapiprazole for patients with night haloes after excimer keratectomy. Graefe s Archive for Clinical and Experimental Ophthalmology. 234(S1). S139–S141. 5 indexed citations
19.
Stolovitch, Chaim, Yair Alster, Anat Loewenstein, & Moshé Lazar. (1995). Influence of the Time Interval Between Instillation of Two Drops of Cyclopentolate 1% on Refraction and Dilation of the Pupil in Children. American Journal of Ophthalmology. 119(5). 637–639. 11 indexed citations
20.
Grossman, Ehud, Yair Alster, Joseph Shemesh, Naomi Nussinovitch, & Talma Rosenthal. (1994). Left ventricular mass in hypertension: correlation with casual, exercise and ambulatory blood pressure.. PubMed. 8(10). 741–6. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Klemens Fondi Breakdown of academic impact, for papers by Alexander H. Rulo Breakdown of academic impact, for papers by Fatih Özçura Breakdown of academic impact, for papers by Nadia Kaiserman Breakdown of academic impact, for papers by M Blumenthal Breakdown of academic impact, for papers by D Chiseliţă Breakdown of academic impact, for papers by Sunil Deokule Breakdown of academic impact, for papers by Shérif M. El-Harazi Breakdown of academic impact, for papers by Velota Sung Breakdown of academic impact, for papers by Tamer Takmaz
Rankless by CCL
2026